For example, miR-338-3p targets PREX2a, a protein that activates PI3K/Akt signaling by confronting PTEN in cancerous cells, and thus suppresses gastric cancer and neuroblastoma [26, 27]. The gene discussed is AKT1; the disease is neuroblastoma.